Schlumberger Limited. (NYSE:SLB) Director Michael E. Marks acquired 3,250 shares of Schlumberger Limited. stock in a transaction dated Monday, October 27th. The shares were purchased at an average cost of $92.59 per share, for a total transaction of $300,917.50. Schlumberger Limited (NYSE:SLB) belongs to Basic Materials sector. Its net profit margin is 14.20% and weekly performance is -2.43%. On last trading day company shares ended up $94.16. Schlumberger Limited (NYSE:SLB) distance from 50-day simple moving average (SMA50) is -6.37%. Marathon Oil Corporation (NYSE:MRO) is in the process of building its budget plan for next year. However, falling oil prices aren’t helping the company at all, but Marathon says it is in it for the long haul even though its third-quarter profits took a hit. Like many companies, Marathon is pushing through the process of figuring out how to spend its money next year. Lee Tillman, CEO of Marathon, says the company is incorporating the recent decrease in oil prices into its calculations and is staying confident that the company’s balance sheet is healthy enough to withstand the battle. Marathon Oil Corporation (NYSE:MRO) shares moved down -3.50% in last trading session and ended the day at $33.36. MRO Gross Margin is 65.60% and its return on assets is 7.30%. Marathon Oil Corporation (NYSE:MRO) quarterly performance is -13.84%. New Media Investment Group (NASDAQ:NEWM) last released its earnings data on Thursday, October 30th. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.09 by $0.24. The company had revenue of $165.10 million for the quarter, compared to the consensus estimate of $159.60 million. Analysts expect that New Media Investment Group will post $0.01 EPS for the current fiscal year. On 04 November, New Media Investment Group Inc. (NYSE:NEWM) shares moved down -0.11% and was closed at $18.77. NEWM EPS growth in last 5 year was 0.00%. New Media Investment Group Inc. (NYSE:NEWM) year to date (YTD) performance is 82.06%. Owens Corning (NYSE:OC) today announced that it is offering to sell, subject to market and other conditions, a new series of its unsecured senior notes in an underwritten public offering under its effective shelf registration statement (the "Senior Notes Offering"). Owens Corning intends to use the net proceeds of the Senior Notes Offering, plus cash on hand, if required, to fund the repurchase of its 9.000% Senior Notes due 2019 (the "2019 Notes") and its 6.500% Senior Notes due 2016 (the "2016 Notes," and together with the 2019 Notes, the "Outstanding Notes") for an aggregate purchase price (including the premium but excluding accrued and unpaid interest) of up to $300 million (the "Maximum Cap") in cash tender offers it commenced today (the "Tender Offers"). Owens Corning (NYSE:OC) ended the last trading day at $31.80. Company weekly volatility is calculated as 1.82% and price to cash ratio as 73.31. Owens Corning (NYSE:OC) showed a weekly performance of 1.53%. Cerulean Pharma Inc. (NASDAQ:CERU), a leader in Dynamic Tumor Targeting™, on 27 October 2014 announced the appointment of clinical oncology expert, David Parkinson, M.D., to its Board of Directors, effective as of October 29, 2014. With Dr. Parkinson's appointment, Cerulean has formed a Clinical Advisory Committee of the Board, which will consist of Dr. Parkinson, Dr. Susan Kelley and Dr. Paul Friedman. Cerulean Pharma Inc. (NASDAQ:CERU) shares increased 0.81% in last trading session and ended the day at $4.99. CERU return on assets is -115.70%. Cerulean Pharma Inc. (NASDAQ:CERU) quarterly performance is 33.07%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
